ARTICLE | Company News
IDAC, Ono Pharmaceutical deal
May 23, 2016 7:00 AM UTC
IDAC granted Ono the exclusive right to evaluate and negotiate a license for IT1208. Ono has rights to evaluate data from a Japanese Phase I trial to treat solid tumors to be conducted by IDAC. IT120...